Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Abetz, Linda ^a   Rajagopalan, Krithika ^b   Mertzanis, Polyxane ^c   Begley, Carolyn ^d   Barnes, Rod ^e   Chalmers, Robin ^f  

^a MAPI VALUES   (United States)

^b SUNOVION PHARMACEUTICALS INC   (United States)

^c Independent consultant   (United States)

^d INDIANA UNIVERSITY   (United States)

^e Health Care Value Evidence   (United States)

^f Clinical Trial Consultant   (United States)

Author keywords

Dry eye; Health related quality of life; Impact; Non sj gren's keratoconjunctivitis sicca; Patient reported outcome; Questionnaire; Sj gren's syndrome; Symptoms; Treatment satisfaction

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CONCURRENT VALIDITY; CONTENT VALIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISCRIMINANT VALIDITY; DRY EYE; FEMALE; HUMAN; IMPACT OF DRY EYE ON EVERYDAY LIFE QUESTIONNAIRE; INSTRUMENT VALIDATION; INTERNAL CONSISTENCY; KERATOCONJUNCTIVITIS SICCA; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PSYCHOMETRY; QUALITY OF LIFE INDEX; QUESTIONNAIRE; SELF REPORT; SHORT FORM 36; SJOEGREN SYNDROME; TEST RETEST RELIABILITY; VISUAL ACUITY; CASE CONTROL STUDY; INFORMATION PROCESSING; MIDDLE AGED; PILOT STUDY; PRINCIPAL COMPONENT ANALYSIS; QUALITY OF LIFE; REPRODUCIBILITY; SELF DISCLOSURE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DRY EYE SYNDROMES; FEMALE; FOCUS GROUPS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PRINCIPAL COMPONENT ANALYSIS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SELF DISCLOSURE;

EID: 82955217289     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-111     Document Type: Article

References (58)

1. Dry Eye Workshop The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007, 5:75-92. Dry Eye Workshop.
2. Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol 2002, 133:181-186. 10.1016/S0002-9394(01)01365-4, 11812420.
3. Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol 2010, 21:310-316.
4. Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Edrington T, Simpson T, Nelson JD, et al. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 2005, 46:46-50. 10.1167/iovs.03-0915, 15623753.
5. Nichols KK, Mitchell GL, Zadnik K. Performance and repeatability of the NEI-VFQ-25 in patients with dry eye. Cornea 2002, 21:578-583. 10.1097/00003226-200208000-00009, 12131034.
6. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000, 118:615-621.
7. Miljanovic B, Dana R, Sullivan DA, Schaumberg DA. Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol 2007, 143:409-415. 10.1016/j.ajo.2006.11.060, 1847608, 17317388.
8. Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, Lemp MA, Sullivan DA. The International Workshop on Meibomian Gland Dysfunction: Executive summary. International Worshop on Meibomian Gland Dysfunction 1922-1929.
9. Pepose JS, Akata RF, Pflugfelder SC, Voigt W. Mononuclear cell phenotypes and immunoglobulin gene rearrangements in lacrimal gland biopsies from patients with Sjogren's syndrome. Ophthalmology 1990, 97:1599-1605.
10. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S, et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993, 36:340-347. 10.1002/art.1780360309, 8452579.
11. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558. 10.1136/ard.61.6.554, 1754137, 12006334.
12. Perry HD. Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care 2008, 14:S79-S87.
13. Begley CG, Chalmers RL, Abetz L, Venkataraman K, Mertzanis P, Caffery BA, Snyder C, Edrington T, Nelson D, Simpson T. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci 2003, 44:4753-4761. 10.1167/iovs.03-0270, 14578396.
14. McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998, 105:1114-1119. 10.1016/S0161-6420(98)96016-X, 9627665.
15. McMonnies CW. Key questions in a dry eye history. J Am Optom Assoc 1986, 57:512-517.
16. Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol 1997, 124:723-728.
17. Chalmers RL, Begley CG, Edrington T, Caffery B, Nelson D, Snyder C, Simpson T. The agreement between self-assessment and clinician assessment of dry eye severity. Cornea 2005, 24:804-810. 10.1097/01.ico.0000154410.99691.3c, 16160496.
18. Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, Pepose JS, Kosheleff V, Porreco A, Lemp MA. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 2010, 51:6125-6130. 10.1167/iovs.10-5390, 20631232.
19. Abetz L, Chalmers R, Begley C, Mertzanis P, Venkataraman K, Barnes R, . IDEEL Study Group The Impact of Dry Eye on Everyday Life (IDEEL) questionnaire: saturation, reliability, validity and discriminative ability compared to generic measures. 2010, IDEEL Study Group.
20. Rajagopalan K, Abetz L, Mertzanis P, Espindle D, Begley C, Chalmers R, Caffery B, Snyder C, Nelson JD, Simpson T, et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eye. Value Health 2005, 8:168-174. 10.1111/j.1524-4733.2005.03074.x, 15804325.
21. Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004, 23:762-770. 10.1097/01.ico.0000133997.07144.9e, 15502475.
22. Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci 2008, 85:668-674. 10.1097/OPX.0b013e318181a947, 18677233.
23. Dry Eye Workshop Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007, 5:163-178. Dry Eye Workshop.
24. Sall K, Stevenson OD, Mundorf TK, Reis BL. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 2000, 107:631-639. 10.1016/S0161-6420(99)00176-1, 10768324.
25. Manthorpe R, Asmussen K, Oxholm P. Primary Sjogren's syndrome: diagnostic criteria, clinical features, and disease activity. J Rheumatol Suppl 1997, 50:8-11.
26. Bandeen-Roche K, Munoz B, Tielsch JM, West SK, Schein OD. Self-reported assessment of dry eye in a population-based setting. Invest Ophthalmol Vis Sci 1997, 38:2469-2475.
27. Begley CG, Caffery B, Nichols K, Mitchell GL, Chalmers R. Results of a dry eye questionnaire from optometric practices in North America. Adv Exp Med Biol 2002, 506:1009-1016. 10.1007/978-1-4615-0717-8_40, 12614024.
28. Bowman SJ, Booth DA, Platts RG, Field A, Rostron J. Validation of the Sicca Symptoms Inventory for clinical studies of Sjogren's syndrome. J Rheumatol 2003, 30:1259-1266.
29. Doughty MJ, Fonn D, Richter D, Simpson T, Caffery B, Gordon K. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom Vis Sci 1997, 74:624-631. 10.1097/00006324-199708000-00023, 9323733.
30. Oden NL, Lilienfeld DE, Lemp MA, Nelson JD, Ederer F. Sensitivity and specificity of a screening questionnaire for dry eye. Adv Exp Med Biol 1998, 438:807-820. 10.1007/978-1-4615-5359-5_113, 9634971.
31. Abetz L, Venkataraman K, Mertzanis P, Chalmers R, Begley C. The Development, Reliability and Validity of a Questionnaire to Assess the Impact of Dry Eyes on Everyday Life (IDEEL). Associaiton for Research in Vision and Ophthalmology 2003, 44.
32. Fairchild CJ, Chalmers RL, Begley CG. Clinically important difference in dry eye: change in IDEEL-symptom bother. Optom Vis Sci 2008, 85:699-707. 10.1097/OPX.0b013e3181824e0d, 18677226.
33. Daniels TE. Labial salivary gland biopsy in Sjogren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984, 27:147-156. 10.1002/art.1780270205, 6696772.
34. Charmaz K. Grounded Theory in the 21st century. The Sage Handbook of Qualitative research 2005, Thousand Oaks, CA: Sage, Denzin NK, Lincoln YS, 3.
35. Murh T. User's Manual for Atlas.ti 6.0 2004, Berlin: Berlin, Atlas.ti.
36. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation variability. Field Methods 2006, 18:59-82.
37. Sandelowski M. Sample size in qualitative research. Research in Nursing and Health 1995, 18:179-183. 10.1002/nur.4770180211, 7899572.
38. Strauss A, Corbin J. Basics of qualitative research: Techniques and procedures for developing Grounded Theory 1998, London: Sage.
39. Ware JE. SF-36 Health Survey - Manual and Interpretation Guide 1993, Boston: The Health Institute, New England Medical Center.
40. Begley CG, Caffery B, Chalmers RL, Mitchell GL. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea 2002, 21:664-670. 10.1097/00003226-200210000-00007, 12352083.
41. The EuroQoL Group EuroQoL - a facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. The EuroQoL Group.
42. Nunnally JC, Bernstein IH. Psychometric theory 1994, New York: McGraw-Hill Inc.
43. Hays RD, Hayashi T. Beyond internal consistency reliability: rationale and user's guide for Multitrait analysis program on the microcomputer. Behav Res Methods Instrum Comput 1990, 22:167-175.
44. Cronbach LJ. Coefficient Alpha and the Internal Structure of Tests. Psychometrika 1951, 16:297-334.
45. Deyo RA, Diehr P, Patrick DL. Reproducibility and Responsiveness of Health Status Measures. Statistics and Strategies for Evaluation. Control Clin Trials 1991, 142-158.
46. Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N. Patient-reported outcomes: The example of health-related quality of life: A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 2002, 36:209-238.
47. Schipper H. Guidelines and caveats for quality of life measurement in clinical practice and research. Oncology (Williston Park) 1990, 4:51-57.
48. Shikiar R, Rentz AM. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004, 7:204-215. 10.1111/j.1524-4733.2004.72252.x, 15164810.
49. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995, 273:59-65. 10.1001/jama.1995.03520250075037, 7996652.
50. Mizuno Y, Yamada M, Miyake Y. Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome. Jpn J Ophthalmol 2010, 54:259-265. 10.1007/s10384-010-0812-2, 20700790.
51. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. , http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf
52. Oliver RL. Satisfaction: A Behavioral Perspective on the Consumer 1997, New York: McGraw-Hill.
53. Dry Eye Workshop Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007, 5:108-152. Dry Eye Workshop.
54. Lemp MA, Bron AJ, Baudouin C, itez Del Castillo JM, Geffen D, Tauber J, Foulks GN, Pepose JS, Sullivan BD. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011, 151:792-798. 10.1016/j.ajo.2010.10.032, 21310379.
55. Buchholz P, Steeds CS, Stern LS, Wiederkehr DP, Doyle JJ, Katz LM, Figueiredo FC. Utility assessment to measure the impact of dry eye disease. Ocul Surf 2006, 4:155-161.
56. Baudouin C, Creuzot-Garcher C, Hoang-Xuan T, Rigeade MC, Brouquet Y, Bassols A, Benmedjahed K, Arnould B. [Creating a specific diagnostic and quality-of-life questionnaire for patients with ocular surface disease]. J Fr Ophtalmol 2003, 26:119-130.
57. Baudouin C, Creuzot-Garcher C, Hoang-Xuan T, Rigeade MC, Brouquet Y, Bassols A, Guillemin I, Benmedjahed K, Arnould B. Severe impairment of health-related quality of life in patients suffering from ocular surface diseases. J Fr Ophtalmol 2008, 31:369-378. 10.1016/S0181-5512(08)71431-1, 18563036.
58. Foulks GN, Sindt C, Griffin J. Efficacy evaluation of a novel emulsion-based, anionic phospholipid-containing artificial tear in meibomian gland dysfunction subjects. 6th International Conference of the Tear Film and Ocular Society (TFOS) 2010,